Ameritas Investment Partners, Inc. Gossamer Bio, Inc. Transaction History

Ameritas Investment Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 05, 2020	BUY	$9.52 - $15.98 $7,739 - $12,991	813 Added 22.8%	4,379 $57,000
Q3 2019 Nov 14, 2019	BUY	$16.02 - $22.47 $29,444 - $41,299	1,838 Added 106.37%	3,566 $60,000
Q2 2019 Aug 14, 2019	BUY	$16.12 - $22.89 $13,105 - $18,609	813 Added 88.85%	1,728 $38,000
Q1 2019 May 15, 2019	BUY	$17.58 - $23.97 $16,085 - $21,932	915 New	915 $20,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $80.8M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.